Top

Supportive Care in Cancer

Published in:

01-01-2016 | Original Article

Identifying trajectory clusters in breast cancer survivors’ supportive care needs, psychosocial difficulties, and resources from the completion of primary treatment to 8 months later

Authors: A. Brédart, O. Merdy, B. Sigal-Zafrani, C. Fiszer, S. Dolbeault, J-B. Hardouin

Published in: Supportive Care in Cancer | Issue 1/2016

Abstract

Purpose

This study aimed to chart patterns of simultaneous trajectories over 8 months in breast cancer survivors’ (BCS) supportive care needs, psychological distress, social support, and posttraumatic growth. Clusters of BCS among these trajectories were identified and characterized.

Methods

Of 426 BCS study participants, 277 (65 %) provided full assessments in the last week of primary cancer treatment and 4 and 8 months later. Latent trajectories were obtained using growth mixture modeling for patients who responded to all scores for at least one time point (n = 348). Then, classification of BCS was performed by hierarchical agglomerative clustering on axes derived from a multiple factor analysis of trajectory assignments. Self-esteem, attachment security, and satisfaction with care were assessed at baseline.

Results

Four trajectory clusters were identified, including two BCS subgroups (63 %) with low needs and low psychological distress. Two others (37 %) exhibited high or increasing needs and concerning levels of psychological distress. These latter clusters were characterized by higher insecure attachment, lower satisfaction with care, and either lower education or younger age, and having undergone chemotherapy.

Conclusion

More than a third of BCS present unfavorable patterns in supportive care needs over 8 months after primary cancer treatment. Identified psychosocial and cancer care characteristics point to targets for enhanced BCS supportive care.

Available only for authorised users

Gysels M, Higginson IJ, Rajasekaran M, Davies E, Harding R (2004) Improving supportive and palliative care for adults with cancer: research evidence. National Institute of Clinical Excellence & Kings College London, London

Burris JL, Armeson K, Sterba KR (2014) A closer look at unmet needs at the end of primary treatment for breast cancer: a longitudinal pilot study. Behav Med: 1-8

Liao MN, Chen SC, Lin YC et al (2012) Changes and predictors of unmet supportive care needs in Taiwanese women with newly diagnosed breast cancer. Oncol Nurs Forum 39:E380–E389CrossRefPubMed

Minstrell M, Winzenberg T, Rankin N, Hughes C, Walker J (2008) Supportive care of rural women with breast cancer in Tasmania, Australia: changing needs over time. Psychooncology 17:58–65CrossRefPubMed

von Heymann-Horan AB, Dalton SO, Dziekanska A et al (2013) Unmet needs of women with breast cancer during and after primary treatment: a prospective study in Denmark. Acta Oncol 52:382–390CrossRef

Fiszer C, Dolbeault S, Sultan S, Brédart A (2014) Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review: prevalence and predictors of supportive care needs in breast cancer. Psychooncology 23(4):361–374CrossRefPubMed

Bower JE (2008) Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26(5):768–777PubMedCentralCrossRefPubMed

Ganz PA, Kwan L, Stanton AL (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96:376–387CrossRefPubMed

Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H (2005) Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 23:4945–4953CrossRefPubMed

10.

Liu J-E, Wang H-Y, Wang M-L, Su Y-L, Wang P-L (2014) Posttraumatic growth and psychological distress in Chinese early-stage breast cancer survivors: a longitudinal study. Psychooncology 23(4):437–443CrossRefPubMed

11.

Tedeschi RG, Calhoun LG (2004) Posttraumatic growth: conceptual foundations and empirical evidence. Psychol Inq 15(1):1–18CrossRef

12.

Mehnert A, Koch U (2008) Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res 64:383–391CrossRefPubMed

13.

Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM (2010) The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast 19(2):84–91CrossRefPubMed

14.

Howlader N, Noone A, Krapcho M, et al.: SEER Cancer Statistics Review, 1975-2011 [Internet]. Bethesda, MD: National Cancer Institute; April 2014. http://seer.cancer.gov/csr/1975_2011/

15.

Allen JD, Savadatti S, Levy AG (2009) The transition from breast cancer ‘patient’ to ‘survivor’. Psychooncology 18:71–78CrossRefPubMed

16.

Schmid-Buchi S, Halfens RJ, Dassen T, van den Borne B (2011) Psychosocial problems and needs of posttreatment patients with breast cancer and their relatives. Eur J Oncol Nurs 15:260–266CrossRefPubMed

17.

Pauwels EE, Charlier C, De Bourdeaudhuij I, Lechner L, Van Hoof E (2013) Care needs after primary breast cancer treatment. Survivors’ associated sociodemographic and medical characteristics. Psychooncology 22:125–132CrossRefPubMed

18.

Lam WW, Shing YT, Bonanno GA, Mancini AD, Fielding R (2012) Distress trajectories at the first year diagnosis of breast cancer in relation to 6 years survivorship. Psychooncology 21:90–99CrossRefPubMed

19.

Helgeson VS, Snyder P, Seltman H (2004) Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol 23(1):3–15CrossRefPubMed

20.

Henselmans I, Helgeson VS, Seltman H, de Vries J, Sanderman R, Ranchor AV (2010) Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol 29(2):160–168CrossRefPubMed

21.

Dunn LB, Cooper BA, Neuhaus J et al (2011) Identification of distinct depressive symptom trajectories in women following surgery for breast cancer. Health Psychol 30:683–692PubMedCentralCrossRefPubMed

22.

Lam WWT, Bonanno GA, Mancini AD et al (2010) Trajectories of psychological distress among Chinese women diagnosed with breast cancer. Psychooncology 19(10):1044–1051CrossRefPubMed

23.

Wang AW-T, Chang C-S, Chen S-T, Chen D-R, Hsu W-Y (2014) Identification of posttraumatic growth trajectories in the first year after breast cancer surgery. Psychooncology. doi:10.1002/pon.3577

24.

McDonough MH, Sabiston CM, Wrosch C (2014) Predicting changes in posttraumatic growth and subjective well-being among breast cancer survivors: the role of social support and stress. Psychooncology 23(1):114–120.CrossRefPubMed

25.

Wang F, Liu J, Liu L et al (2014) The status and correlates of depression and anxiety among breast-cancer survivors in Eastern China: a population-based, cross-sectional case–control study. BMC Public Health 14:326PubMedCentralCrossRefPubMed

26.

Nicholls W, Hulbert-Williams N, Bramwell R (2014) The role of relationship attachment in psychological adjustment to cancer in patients and caregivers: a systematic review of the literature. Psychooncology 23(10):1083–1095CrossRefPubMed

27.

Bredart A, Kop JL, Griesser AC et al (2013) Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care. Ann Oncol 24:2151–2158CrossRefPubMed

28.

Boyes A, Girgis A, Lecathelinais C (2009) Brief assessment of adult cancer patients’ perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). J Eval Clin Pract 15(4):602–606CrossRefPubMed

29.

Zigmond AS, Snaith RP (1983) The hospital anxiety depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed

30.

Tedeschi RG, Calhoun LG (1996) The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress 9(3):455–471CrossRefPubMed

31.

Sarason IG, Sarason BR, Shearin EN, Pierce GR (1987) A brief measure of social support: practical and theoretical implications. J Soc Pers Relat 4(4):497–510CrossRef

32.

Rosenberg M (1965) Society and adolescent child. Princeton University Press, Princeton

33.

Lo C, Walsh A, Mikulincer M, Gagliese L, Zimmermann C, Rodin G (2009) Measuring attachment security in patients with advanced cancer: psychometric properties of a modified and brief experiences in close relationships scale. Psychooncology 18(5):490–499CrossRefPubMed

34.

Brédart A, Bottomley A, Blazeby JM et al (2005) An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32). Eur J Cancer 41:2120–2131CrossRefPubMed

35.

Muthén B, Shedden K (1999) Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics 55(2):463–469CrossRefPubMed

36.

Enders CK (2001) The performance of the full information maximum likelihood estimator in multiple regression models with missing data. Educat Psych Measur 61(5):713–740CrossRef

37.

Sclove SL (1987) Application of model-selection criteria to some problems in multivariate analysis. Psychometrika 52(3):333–343CrossRef

38.

Tofighi D, Enders CK (2008) Identifying the correct number of classes in growth mixture models. advances in latent variable mixture models. Information Age Pub, Charlotte

39.

Kim S-Y (2014) Determining the number of latent classes in single- and multi-phase growth mixture models. Struct Equ Model Multidiscip J 21(2):263–279CrossRef

40.

Celeux G, Soromenho G (1996) An entropy criterion for assessing the number of clusters in a mixture model. J Classif 3(2):195–212CrossRef

41.

Escofier B, Pagès J (1994) Multiple factor analysis (AFMULT package). Comput Stat Data Anal 18(1):121–140CrossRef

42.

Lê S, Josse J, Husson F et al (2008) FactoMineR: an R package for multivariate analysis. J Stat Softw 25(1):1–18CrossRef

43.

Lam WWT, Tsang J, Yeo W et al (2014) The evolution of supportive care needs trajectories in women with advanced breast cancer during the 12 months following diagnosis. Support Care Cancer 22(3):635–644CrossRefPubMed

44.

Ganz PA, Kwan L, Stanton AL, Bower JE, Belin TR (2011) Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol 29:1101–1109PubMedCentralCrossRefPubMed

45.

Grunfeld E, Julian JA, Pond G et al (2011) Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol 29:4755–4762CrossRefPubMed

Title: Identifying trajectory clusters in breast cancer survivors’ supportive care needs, psychosocial difficulties, and resources from the completion of primary treatment to 8 months later
Authors: A. Brédart
O. Merdy
B. Sigal-Zafrani
C. Fiszer
S. Dolbeault
J-B. Hardouin
Publication date: 01-01-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 1/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-015-2799-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2016

In-service documentation tools and statements on palliative sedation in Germany—do they meet the EAPC framework recommendations? A qualitative document analysis

Sleep complaints in survivors of pediatric brain tumors

The need and availability of dental services for terminally ill cancer patients: a nationwide survey in Japan

Risk of thiamine deficiency and Wernicke’s encephalopathy after gastrointestinal surgery for cancer

Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer